Skip to main content
Article thumbnail
Location of Repository

Pharmacokinetics and metabolism of the putative cancer chemopreventive agent cyanidin-3-glucoside in mice

By Timothy H. Marczylo, Darren Cooke, Karen Brown, William P. Steward and Andreas J. Gescher

Abstract

This paper was published as Cancer Chemotherapy and Pharmacology, 2009, 64 (6), pp. 1261-1268. It is available from http://www.springerlink.com/content/dv648q11t9768762/. DOI: 10.1007/s00280-009-0996-7Metadata only entryPurpose: \ud Cyanidin-3-glucoside (C3G), an anthocyanin component of fruits and berries, possesses cancer chemopreventive properties in mouse models of carcinogenesis. Its pharmacokinetics and metabolism in mice have hitherto not been studied. \ud Methods: \ud C57BL6J mice received C3G by either gavage at 500 mg/kg or tail vein injection at 1 mg/kg. Blood, urine, bile and heart, lung, kidney, liver, prostate, brain and gastrointestinal (gi) mucosal tissues were obtained up to 2 h after administration. Levels of C3G and its anthocyanin metabolites were determined by HPLC with visible detection. Metabolites were identified by LC/MS/MS. \ud Results: \ud After oral administration peak concentrations of anthocyanins occurred within 30 min after administration. Levels were highest in the urine and gi mucosa. In the gi mucosa and liver the predominant flavonoid species after oral administration was C3G, whilst after iv dosing the majority of anthocyanins was C3G metabolites. After oral or iv administration, C3G half-lives in the different biofluids and tissues ranged from 0.7 to 1.8 h and 0.3 to 0.7 h, respectively. Systemic bioavailabilities for parent C3G and total anthocyanins were 1.7 and 3.3%, respectively. The major metabolites of C3G were products of methylation and glucuronidation. Cyanidin was a minor metabolite in the gut. \ud Conclusion: \ud C3G and its metabolites were recovered from murine tissues which may be targets for cancer chemopreventive intervention. Anthocyanin levels achieved in the gi mucosa, prostate and the kidneys were of an order of magnitude consistent with pharmacological activity

Topics: Anthocyanins, Cancer chemoprevention, Drug development
Publisher: Springer Verlag
Year: 2009
DOI identifier: 10.1007/s00280-009-0996-7
OAI identifier: oai:lra.le.ac.uk:2381/9490
Journal:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://hdl.handle.net/2381/949... (external link)
  • http://www.springerlink.com/co... (external link)
  • http://dx.doi.org/10.1007/s002... (external link)
  • http://www.springerlink.com/co... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.